L Catterton agreed to sell science-backed health and wellness firm Thorne to Procter & Gamble for $3.8 billion in cash. The definitive deal suggests a positive strategic step for both parties, likely to support PG’s consumer health/wellness expansion.
L Catterton agreed to sell science-backed health and wellness firm Thorne to Procter & Gamble for $3.8 billion in cash. The definitive deal suggests a positive strategic step for both parties, likely to support PG’s consumer health/wellness expansion.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
